Chengdu Kanghong Pharmaceutical Group Co., Ltd

SZSE:002773.SZ

15.14 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 1,117.1621,183.621,092.784958.6471,078.4081,035.566884.839757.458868.178868.18895.212760.567944.915985.325914.54947.46954.625760.623632.723847.782890.917801.715717.016734.983799.158683.313699.991687.052730.193727.213642.039709.471666.135640.823523.602603.569579.735490.033401.016545.071429.097396.126304.224
Cost of Revenue 111.235150.87114.857111.983111.533110.953103.9498.48992.61398.77998.15480.03993.7894.48286.305100.0698.35169.95161.37577.99970.32959.88655.63663.18259.92247.92857.47469.35465.38270.81763.73966.72859.43461.09756.35964.39859.74101.36448.01560.352.47480.7160
Gross Profit 1,005.9271,032.75977.928846.664966.875924.613780.899658.969775.565769.401797.058680.528851.135890.843828.234847.4856.274690.672571.347769.783820.588741.829661.38671.801739.236635.385642.517617.698664.811656.395578.3642.743606.701579.726467.243539.171519.995388.668353.001484.771376.623315.411304.224
Gross Profit Ratio 0.90.8730.8950.8830.8970.8930.8830.870.8930.8860.890.8950.9010.9040.9060.8940.8970.9080.9030.9080.9210.9250.9220.9140.9250.930.9180.8990.910.9030.9010.9060.9110.9050.8920.8930.8970.7930.880.8890.8780.7961
Reseach & Development Expenses 149.284117.14263.846163.3388.25101.43568.663139.306102.51677.44854.728426.38136.95247.591197.4441,519.38453.51458.12245.04899.53387.57453.40246.43478.9863.77955.15732.45105.33830.96355.6320122.233043.802099.389033.339075.497034.1560
General & Administrative Expenses 247.085-2.2395.452-139.861235.162-21.88393.026-106.948184.791-10.63682.036-96.399197.03-8.34969.81459.0771.6676.1462.322-39.84879.15723.1667.99917.54775.352-10.38987.294-105.70597.05923.81680.431-82.60588.12918.06572.996-62.14965.72166.43549.215-48.63256.1108.2550
Selling & Marketing Expenses 701.077469.974387.756295.158434.369440.185301.157271.588370.092351.825326.73273.243415.523393.063321.793291.662462.36375.607277.121375.917428.761454.684308.145239.598393.363425.185317.477154.741358.572442.628321.053322.852364.88387.383270.347278.67307.24295.794216.27251.842217.158401.9460
SG&A 948.162585.785483.208155.297669.532418.302394.183164.64554.883341.189408.766176.844612.553384.714391.608350.732534.027381.747339.443336.069507.918477.844376.144257.145468.716414.796404.77149.036455.631466.444401.484240.247453.009405.447343.344216.521372.961365.555265.485203.21273.258513.7770
Other Expenses -419.713-0.746-0.557-14.814-3.692-8.324-6.121240.58-109.77299.468-9.0218.8319.9791.73-2.297-21.583-2.0122.67113.69910.1138.83-2.956-1.559-8.763-3.27817.115-1.822-22.96-3.5332.455-0.42716.8471.207-0.705-0.62719.65-1.205-318.892-319.9730.9861.862-277.235-243.194
Operating Expenses 677.734703.673547.548615.904619.313661.055456.725544.525547.627518.105454.473794.661639.642728.941579.8052,059.774578.379526.382375.249616.63586.071607.876413.986483.685525.956555.75397.001300.275466.483577.718411.336465.926462.936497.713351.651407.107381.954-318.892-319.973361.254280.498-277.235-243.194
Operating Income 328.193329.077446.538265.697364.817294.56335.993145.693248.561269.261351.853-307.164224.784181.125256.432-1,189.221294.455181.352201.126171.416247.416149.334252.586211.481229.931108.668246.124310.802211.61991.482173.627193.869152.29691.804118.77143.973143.02369.77681.043132.4797.88538.17661.03
Operating Income Ratio 0.2940.2780.4090.2770.3380.2840.380.1920.2860.310.393-0.4040.2380.1840.28-1.2550.3080.2380.3180.2020.2780.1860.3520.2880.2880.1590.3520.4520.290.1260.270.2730.2290.1430.2270.2390.2470.1420.2020.2430.2280.0960.201
Total Other Income Expenses Net -7.3242.24-0.557-13.981-3.692-8.324-1.1539.739-0.886.545-0.47618.8320.0911.73-2.297-21.583-1.9252.67113.69910.1138.83-2.956-1.559-8.763-3.27817.115-1.822-22.91-6.0682.451-0.43411.251.199-0.766-0.66817.506-1.2120.8761.399-0.4881.791.8814.872
Income Before Tax 320.873371.37445.982251.716361.125286.236334.84155.432247.681275.806351.377-288.334244.763182.856254.135-1,210.804292.443184.023214.825181.529256.245146.378251.027202.718226.653125.783244.303287.891208.04693.932173.194205.119153.49591.037118.102161.479141.81170.65282.442131.98399.67640.05765.902
Income Before Tax Ratio 0.2870.3140.4080.2630.3350.2760.3780.2050.2850.3180.393-0.3790.2590.1860.278-1.2780.3060.2420.340.2140.2880.1830.350.2760.2840.1840.3490.4190.2850.1290.270.2890.230.1420.2260.2680.2450.1440.2060.2420.2320.1010.217
Income Tax Expense 42.51956.25574.50736.79964.62543.72457.64539.58231.61538.40854.88-56.27312.112-420.501-361.90647.97826.04638.22315.60844.25817.10140.02214.23130.4821.48638.31659.35825.44812.46121.59717.20519.79115.08915.54814.16519.924339.918-305.69526.59714.941259.522-232.645
Net Income 281.492318.699373.521219.404300.022246.008279.331141.971217.612239.847297.24-232.058232.652186.856233.634-848.898244.465157.977176.602165.921211.987129.277211.005188.487196.173104.297205.986228.533182.59881.471151.597186.198132.41876.151101.985144.72121.06759.86368.163103.08384.09530.95155.353
Net Income Ratio 0.2520.2690.3420.2290.2780.2380.3160.1870.2510.2760.332-0.3050.2460.190.255-0.8960.2560.2080.2790.1960.2380.1610.2940.2560.2450.1530.2940.3330.250.1120.2360.2620.1990.1190.1950.240.2090.1220.170.1890.1960.0780.182
EPS 0.310.350.410.240.330.270.30.150.240.260.32-0.260.250.20.25-10.280.180.20.190.240.150.240.210.220.120.240.260.210.0940.180.210.150.0880.120.170.140.0690.0870.130.110.040.079
EPS Diluted 0.310.350.410.240.330.270.30.150.230.260.32-0.260.250.20.25-0.970.280.180.20.190.240.150.240.210.220.120.230.260.210.0940.170.210.150.0880.120.170.140.0690.0870.130.110.040.079
EBITDA 312.465429.476504.141309.826419.312341.04389.651114.444289.677314.924390.558-178.457283.255220.077291.375-1,179.254324.016213.311244.022208.013282.784167.784272.451188.116213.2879.635249.576317.422200.82480.323170.362222.954143.76493.547119.075176.808138.04-247.795401.016149.81196.125-212.24304.224
EBITDA Ratio 0.280.3270.3940.2410.3230.2540.3680.1540.2620.2910.383-0.020.1960.1910.271-1.2770.3060.240.340.1790.2640.1670.350.2560.2690.1150.3570.5040.2720.110.2650.3220.2170.1470.2270.2910.24-0.50610.2710.226-0.5361